Futures slip, bank earnings ahead, Powell to speak - what’s moving markets
Cathie Wood’s ARK ETFs have disclosed their daily trades for Friday, September 12th, 2025, revealing a series of strategic moves in the tech and finance sectors. Leading the pack with the highest dollar-value trade, ARK’s ARKW fund purchased 151,501 shares of design platform Figma Inc (NASDAQ:FIG), amounting to a substantial investment of $8,477,995. This purchase underscores ARK’s growing interest in the creative software space, as Figma continues to disrupt the industry with its collaborative interface design tools.
In the fintech arena, ARK’s ARKF fund bolstered its position in Bullish (NYSE:BLSH) by adding 45,037 shares valued at $2,431,547. This acquisition follows a pattern of consistent buying in the previous days, signaling ARK’s confidence in Bullish’s potential within the digital currency exchange market.
ARKF also increased its stake in social trading and investment network eToro Group Ltd (NASDAQ:ETOR) by purchasing 33,710 shares, translating to an investment of $1,496,386. This move comes after a series of buys in recent days, highlighting a clear trend of ARK consolidating its position in eToro, which has been gaining traction for its user-friendly platform that allows individuals to invest in a variety of financial instruments.
The fund continued to diversify its portfolio with a purchase of 36,685 shares of Toast Inc (NYSE:TOST), a cloud-based restaurant software company, for a total of $1,496,381. This investment aligns with ARK’s focus on innovative companies that leverage technology to transform traditional industries.
On the sell side, ARK’s ARKG fund reduced its holdings in Tempus AI Inc (PRE-REINCORPORATION) (NYSE:TEM), offloading 2,636 shares at a value of $234,024. This sale marks a continuation of ARK’s gradual exit from Tempus, a company specializing in artificial intelligence and precision medicine, as seen in previous trade reports.
Finally, ARKG also acquired 25,710 shares of Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the development of novel RNA therapeutics, for a total of $463,808.
Investors and market watchers closely follow Cathie Wood’s ARK ETFs for their forward-looking investments in disruptive innovation. Today’s trades provide a window into ARK’s latest strategic decisions, as the fund navigates a rapidly evolving market landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.